Bill > HB165

This bill modifies several sections of Missouri law to expand provisions related to epinephrine products, specifically by adding single-use epinephrine nasal spray devices alongside existing auto-injector devices. The bill updates regulations for schools, emergency medical services, authorized entities, and first responders to include these nasal spray devices in their protocols for managing anaphylaxis (a severe allergic reaction). Key changes include allowing schools to maintain and staff members to administer nasal spray epinephrine, permitting authorized entities like restaurants and sports venues to stock and use these devices, and enabling first responders to be trained in and use both auto-injector and nasal spray forms of epinephrine. The bill also establishes training requirements, liability protections for those who administer the medication in good faith, and creates a dedicated fund for providing epinephrine devices to qualified first responder agencies. Throughout the bill, the language consistently adds "single-use epinephrine nasal spray" as an equivalent option to epinephrine auto-injectors, effectively expanding the available emergency treatment options for severe allergic reactions.

https://house.mo.gov/Bill.aspx?bill=HB165&year=2025&code=R